4//SEC Filing
O'Keeffe Charles B 4
Accession 0001161697-23-000651
CIK 0001369568other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:00 PM ET
Size
7.6 KB
Accession
0001161697-23-000651
Insider Transaction Report
Form 4
O'Keeffe Charles B
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-12-27−1,333→ 292,931 total→ Common Stock (1,333 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2023-12-27+1,333→ 621,724 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
- [F3]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 27, 2023.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001378656
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 5:00 PM ET
- Size
- 7.6 KB